chr8-18057617-C-T

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 2P and 20B. PM1BP4_StrongBP6_Very_StrongBS1BS2

The NM_177924.5(ASAH1):​c.1105G>A​(p.Val369Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00254 in 1,598,538 control chromosomes in the GnomAD database, including 50 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V369A) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0041 ( 5 hom., cov: 32)
Exomes 𝑓: 0.0024 ( 45 hom. )

Consequence

ASAH1
NM_177924.5 missense

Scores

4
14

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 2.09
Variant links:
Genes affected
ASAH1 (HGNC:735): (N-acylsphingosine amidohydrolase 1) This gene encodes a member of the acid ceramidase family of proteins. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed. Processing of this preproprotein generates alpha and beta subunits that heterodimerize to form the mature lysosomal enzyme, which catalyzes the degradation of ceramide into sphingosine and free fatty acid. This enzyme is overexpressed in multiple human cancers and may play a role in cancer progression. Mutations in this gene are associated with the lysosomal storage disorder, Farber lipogranulomatosis, and a neuromuscular disorder, spinal muscular atrophy with progressive myoclonic epilepsy. [provided by RefSeq, Oct 2015]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 10 uncertain in NM_177924.5
BP4
Computational evidence support a benign effect (MetaRNN=0.0107887685).
BP6
Variant 8-18057617-C-T is Benign according to our data. Variant chr8-18057617-C-T is described in ClinVar as [Benign]. Clinvar id is 362373.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-18057617-C-T is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.00407 (619/152246) while in subpopulation EAS AF = 0.0232 (120/5182). AF 95% confidence interval is 0.021. There are 5 homozygotes in GnomAd4. There are 337 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position FAILED quality control check.
BS2
High Homozygotes in GnomAd4 at 5 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ASAH1NM_177924.5 linkc.1105G>A p.Val369Ile missense_variant Exon 14 of 14 ENST00000637790.2 NP_808592.2 Q13510-1Q53H01A8K0B6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ASAH1ENST00000637790.2 linkc.1105G>A p.Val369Ile missense_variant Exon 14 of 14 1 NM_177924.5 ENSP00000490272.1 Q13510-1

Frequencies

GnomAD3 genomes
AF:
0.00405
AC:
616
AN:
152130
Hom.:
5
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00164
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0229
Gnomad ASJ
AF:
0.00259
Gnomad EAS
AF:
0.0229
Gnomad SAS
AF:
0.00186
Gnomad FIN
AF:
0.00283
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000338
Gnomad OTH
AF:
0.00431
GnomAD2 exomes
AF:
0.00877
AC:
2200
AN:
250950
AF XY:
0.00709
show subpopulations
Gnomad AFR exome
AF:
0.00142
Gnomad AMR exome
AF:
0.0376
Gnomad ASJ exome
AF:
0.00298
Gnomad EAS exome
AF:
0.0330
Gnomad FIN exome
AF:
0.00347
Gnomad NFE exome
AF:
0.000846
Gnomad OTH exome
AF:
0.00718
GnomAD4 exome
AF:
0.00238
AC:
3447
AN:
1446292
Hom.:
45
Cov.:
30
AF XY:
0.00215
AC XY:
1545
AN XY:
719872
show subpopulations
Gnomad4 AFR exome
AF:
0.000755
AC:
25
AN:
33092
Gnomad4 AMR exome
AF:
0.0374
AC:
1653
AN:
44220
Gnomad4 ASJ exome
AF:
0.00306
AC:
78
AN:
25474
Gnomad4 EAS exome
AF:
0.0223
AC:
862
AN:
38626
Gnomad4 SAS exome
AF:
0.000895
AC:
77
AN:
86010
Gnomad4 FIN exome
AF:
0.00457
AC:
237
AN:
51910
Gnomad4 NFE exome
AF:
0.000285
AC:
314
AN:
1101922
Gnomad4 Remaining exome
AF:
0.00339
AC:
201
AN:
59356
Heterozygous variant carriers
0
168
337
505
674
842
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
52
104
156
208
260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00407
AC:
619
AN:
152246
Hom.:
5
Cov.:
32
AF XY:
0.00453
AC XY:
337
AN XY:
74434
show subpopulations
Gnomad4 AFR
AF:
0.00164
AC:
0.00163713
AN:
0.00163713
Gnomad4 AMR
AF:
0.0230
AC:
0.0229652
AN:
0.0229652
Gnomad4 ASJ
AF:
0.00259
AC:
0.00259366
AN:
0.00259366
Gnomad4 EAS
AF:
0.0232
AC:
0.0231571
AN:
0.0231571
Gnomad4 SAS
AF:
0.00186
AC:
0.0018649
AN:
0.0018649
Gnomad4 FIN
AF:
0.00283
AC:
0.00282805
AN:
0.00282805
Gnomad4 NFE
AF:
0.000338
AC:
0.000338106
AN:
0.000338106
Gnomad4 OTH
AF:
0.00427
AC:
0.00426945
AN:
0.00426945
Heterozygous variant carriers
0
32
63
95
126
158
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00261
Hom.:
20
Bravo
AF:
0.00608
ESP6500AA
AF:
0.00159
AC:
7
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.00719
AC:
873
Asia WGS
AF:
0.0110
AC:
38
AN:
3478
EpiCase
AF:
0.0000545
EpiControl
AF:
0.00

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:6
Dec 30, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ASAH1: BP4, BS1, BS2 -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Dec 15, 2015
Mayo Clinic Laboratories, Mayo Clinic
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Apr 02, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 29140481) -

not specified Benign:1
Sep 30, 2024
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Farber lipogranulomatosis Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

ASAH1-related disorders Benign:1
May 17, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.36
T
BayesDel_noAF
Benign
-0.26
CADD
Benign
21
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.46
T;T;T;.;T;T;T;T;T;T;T;.;.;.
Eigen
Uncertain
0.25
Eigen_PC
Benign
0.21
FATHMM_MKL
Benign
0.65
D
LIST_S2
Uncertain
0.86
.;D;D;D;D;.;D;D;D;D;D;D;D;D
MetaRNN
Benign
0.011
T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.51
T
MutationAssessor
Benign
1.7
L;L;.;.;.;.;.;.;.;.;.;.;.;.
PrimateAI
Benign
0.28
T
PROVEAN
Benign
-0.83
.;N;N;N;.;.;.;.;.;.;.;.;.;N
REVEL
Benign
0.24
Sift
Benign
0.064
.;T;T;D;.;.;.;.;.;.;.;.;.;T
Sift4G
Benign
0.17
.;T;T;T;.;.;.;.;.;.;.;.;.;T
Polyphen
0.92
P;P;D;P;.;.;.;.;.;.;.;.;.;.
Vest4
0.052, 0.076, 0.070, 0.081
MVP
0.79
MPC
0.0036
ClinPred
0.011
T
GERP RS
5.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.053
gMVP
0.75
Mutation Taster
=92/8
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs17636067; hg19: chr8-17915126; API